NikeSKIMS exists to serve women who are redefining what it means to be an athlete today. It’s within this vision that NikeSKIMS debuts its inaugural apparel collection launching on September 26, which is designed to sculpt and engineered to perform, without compromise. Built from Nike’s (NYSE:NKE) unparalleled relationship with athletes and SKIMS’ solutions-first approach, NikeSKIMS delivers what no other brand can: a new aesthetic and system of dress, obsessively crafted for the body, from the...

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company today announced having signed a license agreement for SunRock Biopharma’s SRB21, an HER3/HER2 antibody. SunRock Biopharma is a Galician company supported by the regional government, Xunta de Galicia, through Xesgalicia, devoted to the development of antibodies against highly invasive tumors with an urgent clinical need in oncology. Debiopharm has exercised its option to license SunRock Biopharma's bispeci...

Ralph Lauren (NYSE: RL) announces today that it will open a new restaurant as part of its renowned hospitality portfolio, The Polo Bar Ralph Lauren in London. The restaurant will be located at 1 Hanover Square and is set to open in 2028. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930206173/en/The Polo Bar Ralph Lauren Building on the international acclaim of The Polo Bar, which opened in New York in 2015 and quickly became a ...

Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the Netherlands-based Single Cell Discoveries as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, Single Cell Discoveries will expand access to Parse’s single cell technology, pairing it with a team uniquely dedicated to single cell science to support researchers across Europe and worldwide. Introduced in 2024, the CSP Program connects researchers w...